Zheng Zhang

Dr. Zheng Zhang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
BJBing Jiang
Bing Jiang
XZXuan Zhou
Xuan Zhou
TYTao Yang
Tao Yang
LWLinlin Wang
Linlin Wang
LFLongfei Feng
Longfei Feng
ZZZheng Zhang
Zheng Zhang
Autophagy is a conserved lysosomal pathway for the degradation of cytoplasmic proteins and organelles, which realizes the metabolic needs of cells and the renewal of organelles. Autophagy-related genes (ATGs) are the main molecular mechanisms controlling autophagy, and their functions can coordinate the whole autophagic process. Autophagy can also play a role in cardiovascular disease through several key signaling pathways, including PI3K/Akt/mTOR, IGF/EGF, AMPK/mTOR, MAPKs, p53, Nrf2/p62, Wnt/β-catenin and NF-κB pathways. In this paper, we reviewed the signaling pathway of cross-interference between autophagy and cardiovascular diseases, and analyzed the development status of novel cardiovascular disease treatment by targeting the core molecular mechanism of autophagy as well as the critical signaling pathway. Induction or inhibition of autophagy through molecular mechanisms and signaling pathways can provide therapeutic benefits for patients. Meanwhile, we hope to provide a unique insight into cardiovascular treatment strategies by understanding the molecular mechanism and signaling pathway of crosstalk between autophagy and cardiovascular diseases.

9 December 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
BJBing Jiang
Bing Jiang
YWYan Wang
Yan Wang
XZXiaodong Zhi
Xiaodong Zhi
ALAi Liu
Ai Liu
LWLingyun Wang
Lingyun Wang
ZZZheng Zhang
Zheng Zhang

30 November 2022 in Research Square
Verified
Preprint
Open access
PDF file
BJBing Jiang
Bing Jiang
XFXin Feng
Xin Feng
ZWZheng Wang
Zheng Wang
JXJin Xu
Jin Xu
TYTao Yang
Tao Yang
ZZZheng Zhang
Zheng Zhang
Background Salidroside (Sal) has many pharmacological effects, including anti-fatigue, anti-aging, immunoregulation and so on. However, its effects and related regulatory mechanisms on coronary artery disease (CAD) are elusive. We hypothesize that Sal may play a role in CAD through autophagic pathway. Herein, we used autophagy agonist (sirolimus, Sir) and inhibitor (chloroquine diphosphate, CQ) as the autophagic control group. And network pharmacology prediction was employed to explore the pharmacological effects and molecular mechanisms of Sal on CAD using network pharmacology prediction, and validated the results through in vitro experiments. Methods Through a search in the Swisstarget Prediction database, chemical composition and targets were retrieved. The related-autophagic targets for CAD were then obtained from the GEO and human autophagy databases. The network was constructed that depicted the interactions between putative drugs (Sal, Sir and CQ) and known related-autophagic targets for CAD using Cytoscape 3.8.0. Analysis of protein-protein interaction (PPI) was achieved via STRING software, followed by gene ontology (GO) functional enrichment and kyoto enrichment of gene and genome (KEGG) pathway analyses. The 3D structure of target protein was downloaded from RSCB PDB database, the 2D structure of drug was obtained from PubChem database, then the molecular docking was constructed by using AutoDockTools 1.5.6 and AutoDock Vina software, and the results were visualized by using PyMoL sofeware. To validate the computer-predicted results, in vitro experiments based on an anoxic injury model were designed by using CoCl2-exposed H9C2 cells, and treated with various concentrations of Sal/Sir/CQ. The effects of drugs on cells were detected by using the CCK-8, inverted microscope (IM), transmission electron microscope (TEM), MDC staining and AO staining. Moreover, the expression profiles of related-proteins were analyzed via western blot. Results Three compounds were identified a total of 399 targets, GEO revealed a total of 576 CAD-related genes, and 36 overlapping genes of drug-disease were obtained. The PPI network was employed for the analysis of 36 target proteins, including CASP3, mTOR, VEGFA and EGFR. The enrichment analysis demonstrated candidate targets of three compounds were more frequently involved in inflammation, lipid response, oxidative stress, autophagy, apoptosis, diabetic cardiomyopathy and estrogen signaling pathways. In vitro experiments revealed that Sal could induce autophagy in CoCl2-exposed H9C2 cells, significantly reverse cell death in the early period, and decrease the levels of Caspase-3 protein in CoCl2-exposed H9C2 cells. However, Sal-induced autophagy also could promoted the process of CoCl2-exposed H9C2 cells death in the late period. Conclusions This study revealed that Sal existed the effect of treating CAD by regulating multi-targets and multi-channels through the method of network pharmacology. Furthermore, in vitro results confirmed that Sal-induced autophagy played a protective role in the early period of CAD, while aggravated the condition in the late period of CAD.